GPCR
Income statement / Annual
Last year (2024), Structure Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Structure Therapeutics Inc.'s net income was -$122.53 M.
See Structure Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$949,174.00
|
$623,258.00
|
$266,353.00
|
$20,034.00
|
| Gross Profit |
$0.00
|
-$949,174.00
|
-$623,258.00
|
-$266,353.00
|
-$20,034.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$108.81 M
|
$70.10 M
|
$36.19 M
|
$29,111.00
|
$12,364.00
|
| General & Administrative Expenses |
$49.41 M
|
$32.67 M
|
$16.37 M
|
$8,585.00
|
$3,542.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$49.41 M
|
$32.67 M
|
$16.37 M
|
$8,585.00
|
$3,542.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$158.23 M
|
$102.78 M
|
$52.56 M
|
$37,696.00
|
$15,906.00
|
| Cost And Expenses |
$0.00
|
$102.78 M
|
$52.56 M
|
$37,696.00
|
$15,906.00
|
| Interest Income |
$0.00
|
$13.38 M
|
$1.26 M
|
$122.00
|
$168,289.00
|
| Interest Expense |
$0.00
|
$13.39 M
|
$0.00
|
$122,161.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$316,000.00
|
$623,258.00
|
$266,353.00
|
$20,034.00
|
| EBITDA |
-$158.23 M |
-$102.46 M |
-$52.28 M |
-$37.62 M |
-$15.75 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$36.01 M
|
$13.39 M
|
$1.26 M
|
-$122,000.00
|
$168,000.00
|
| Income Before Tax |
-$122.22 M
|
-$89.38 M
|
-$51.30 M
|
-$37,818.00
|
-$15,738.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$310,000.00
|
$236,000.00
|
$17,000.00
|
$231.00
|
$138.00
|
| Net Income |
-$122.53 M
|
-$89.62 M
|
-$51.32 M
|
-$38,049.00
|
-$15,876.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.78 |
-0.20313 |
-0.11655 |
-8.325E-5 |
-3.33E-5 |
| EPS Diluted |
-0.78 |
-0.20313 |
-0.11655 |
-8.325E-5 |
-3.33E-5 |
| Weighted Average Shares Out |
$157.92 M
|
$440.78 M
|
$439.06 M
|
$439.06 M
|
$439.06 M
|
| Weighted Average Shares Out Diluted |
$157.92 M
|
$440.79 M
|
$439.06 M
|
$439.06 M
|
$439.06 M
|
| Link |
|
|
|
|
|
